Elon Musk’s brain-implant company Neuralink on Thursday said it had received Food and Drug Administration’s approval to launch the first-in-human clinical study.
Several times since 2019, billionaire Elon Musk has predicted his brain-chip company would soon secure FDA approval for human trials. But the corporate’s application was rejected in early 2022, and the corporate was working through the agency’s concerns over the security of the experimental implant.
“That is the results of incredible work by the Neuralink team in close collaboration with the FDA and represents a very important first step that may in the future allow our technology to assist many individuals,” Neuralink said in a tweet on Thursday.
Neuralink added that the corporate will not be yet open for a clinical trial.
Neuralink is developing a brain implant it hopes will help paralyzed people walk again and cure other neurological ailments.
Several times since 2019, billionaire Elon Musk has predicted his brain-chip company would soon secure FDA approval for human trials. REUTERS
Neuralink is developing a brain implant it hopes will help paralyzed people walk again and cure other neurological ailments.Getty Images/iStockphoto
The FDA didn’t immediately reply to Reuters request for comment.
Musk has said he’s comfortable implanting a chip into certainly one of his own children’s brains if the necessity arose.
